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the first 3 years of treatment with stimulant medication.
Whether this is associated with delay in the rate of skeletal
maturation is unknown. Our aim was to investigate the effect of
stimulant medication on bone age, height and weight.
Methods Prospective longitudinal study of the first 3 years of
treatment with stimulant medication in children with ADHD
compared with their unaffected siblings. X-rays of the non-domi-
nant wrist and hand were taken at baseline and 3 years. The
films were read independently by 2 radiologists blinded to date,
age and group allocation. The bone age was calculated using
Tanner and Whitehouse version 3 which uses staging of the
radius, ulna and 11 small bones of the hand to compile a RUS
score which is converted to bone age using gender specific refer-
ence data. Height and weight were monitored. The dose of
stimulant medication (dexamphetamine or methylphenidate) was
titrated with the aim of achieving the best clinical response with
the lowest possible dose of medication. Groups were compared
using independent samples t-tests. Correlations used Pearson’s r.
Results From 2003–2009, 70 children with ADHD and 36 sib-
lings aged 2.5–11.6 years had baseline X-rays, repeated after
3 years in 40 and 20 respectively. The correlation between the
reporting of the radiologists was r = 0.96, p < 0.001. Over
3 years the ADHD children grew significantly more slowly than
their sibling controls (5.2 ± 1.0 and 6.7 ± 1.2 cm/year, p <
0.0001; 2.9 ± 1.9 and 4.6 ± 2.5 kg/year, p = 0.005). The bone
age progression was not significantly different between groups for
either radiologist. The bone age changed by 2.90 ± 0.85 years in
the subjects and 3.13 ± 1.07 years in the controls, p = 0.4 (calcu-
lated from the average of the 2 radiologists’ scores).
Conclusions Despite significant differences in growth rates, the
children with ADHD showed no significant delay in their rate of
skeletal maturation compared to a group of healthy siblings. A
slower growth rate in association with a normal rate of matura-
tion could have adverse implications for growth potential.
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Aims NMDAR-antibody encephalitis presents in adults and chil-
dren with neuropsychiatric features, seizures, movement disor-
ders and autonomic instability. This BPNSU study aimed to
report the clinical features, management and neurological out-
comes of UK paediatric patients.
Methods An initial and follow-up questionnaire was sent out to
physicians following voluntary reporting of confirmed cases of
NMDAR-antibody encephalitis through the BPNSU. Out of 35
cases notified, 31 met the case definition.
Results The majority of patients were female (23/31; 74%; age
range 22 months to 17 years) most presenting in pre-school and
teenage years. Male patients only presented from school age (age
range 6 to 17 years), which was significantly different to the
female presentation age range (p = 0.03). 55% of the patients
were Caucasian. The most common presenting symptoms were
neuropsychiatric (28/31), behavioural change (27/31), and seiz-
ures (21/31). Movement disorder was present in 67% of patients
(21/31); in 3 patients this was the only symptom. Atypical or
monosymptomatic presentations (e.g. neuropsychiatric features
only) occurred in 7 patients. EEG was the most frequently
abnormal investigation (28/21; 93%). An ovarian teratoma was
found in one patient. First-line immunotherapy was used in all
cases. The most commonly used 2nd line agents were cyclophos-
phamide (3), rituximab (3) or both (3). Most patients showed a
response to immunotherapy within 30 days. Thirteen patients
required ICU admission (13/31; 42%). The average in-patient
stay was 80 days (range 10 – 365 days). Patients required, on
average, the involvement of 4 additional health professionals to
the admitting team. Only 1 patient in the retrospectively diag-
nosed group (n = 7) made a full eventual recovery, compared to
78% (18/23) of the prospective group (p = 0.003). 7 patients
suffered a relapse; 3 of these had an atypical presentation, mak-
ing relapse more common in this group (3/7; 43%) compared to
the patients with a more typical presentation (4/19; 21%).
Conclusions In the UK, paediatric NMDAR-antibody encephali-
tis presents mainly in females with neuropsychiatric features,
behavioural change and seizures, usually supported by an abnor-
mal EEG. Tumours are uncommon. Monosymptomatic presenta-
tions exist and frequently relapse. Patients do better if diagnosed
at the time of presentation. Prolonged hospital admission is com-
mon and requires a multi-disciplinary approach.
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Aims Paediatric Emergency Research in the UK and Ireland
(PERUKI) is a research collaborative that was established in
August 2012. It consists of 40 centres from England, Ireland,
Northern Ireland, Scotland and Wales, and aims to improve the
emergency care of children through the performance of robust
collaborative multicentre research within Emergency Depart-
ments (EDs).
A study was conducted to establish the research priorities of
PERUKI, in order to direct potential projects and to share these
priorities with funding agencies to inform future calls for study
proposals.
Methods A 2-stage modified Delphi survey was conducted of all
PERUKI members via an online survey platform. Round 1
allowed each member to submit up to 12 individual questions in
“PICO” format that they identified as priorities for future
research. From this total bank of responses, a list of all unique
research questions was compiled, grouped by subject area/topic.
A shortlist of eligible questions was then drawn up by the
PERUKI Executive Committee during a teleconference analysis
discussion. Questions were considered to be eligible for further
consideration if they were unanswered in the current literature
and if they leant themselves to multi-centre research within EDs.
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In Round 2, members reviewed each of the shortlisted ques-
tions and rated each on a 7-point Likert scale of relative impor-
tance to clinical practice in Paediatric Emergency Medicine.
Questions were then ranked according to total priority score.
Results Round 1:
Response rate = 46/91 (51%)
Total questions 249
Total unique questions 206
Shortlisted eligible questions 60
Round 2:
Response rate = 58/95 (61%)
After ranking, the top 10 priorities included questions on bio-
markers for serious bacterial illness, major trauma, intravenous
bronchodilators for asthma, and decision rules for fever with
petechiae, head injury and atraumatic limp.
Conclusion Research priorities of PERUKI members have been
identified. We are dovetailing this with the next step of identify-
ing relevant funding bodies to progress research in these areas of
Paediatric Emergency Medicine.
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Over the last ten years there has been a steady rise in short paedi-
atric admissions. This is likely to be multi-factorial but is in part
attributed to the introduction of the four hour Emergency Depart-
ment (ED) target and changes in primary care provision. Head
injury is the most common paediatric injury presentation. The
National Institute for Health and Care Excellence (NICE) pub-
lished guidance for head injury management in 2003 and 2007.
Both prioritised early definitive diagnosis by early brain imaging
although paediatric practice often includes a period of observa-
tion. We aimed to establish whether introduction of national guid-
ance resulted in significant change of death or admission rates.
Methods A retrospective observational study of admissions and
deaths due to paediatric head injury between 2000 and 2012
was performed using Hospital Episode Statistics and Office for
National Statistics publications.
Results – See Figures 1-3.
Correcting for changes in population size, per 100,00 chil-
dren aged 0–14 years there is a downward trend in mortality
(Figure 1) (R2 = 0.7 p < 0.001) but an upward trend in admis-
sion rates (Figure 2) (R2 = 0.3 p = 0.05). Admission rates for
paediatric head injury as a percentage of all admissions decreased
(Figure 3) (R2 = 0.65 p < 0.001).
Conclusion We have found statistically significant changes in rates
of death and admission due to paediatric head injury over this
time period. However even accounting for implementation delays,
the trends that we have demonstrated do not directly correlate
with the timings of national guidance, ED targets or changes to
primary care provision. For a more complete understanding of the
impact of the guidelines this analysis should now be expanded to
incorporate ED attendance rates and length of stay. However
these existing data provide a useful benchmark against which to
compare the effect of the 2014 update to NICE guidance.
Abstract G13 Figure 1 Annual number of head injury admissions per
100 000 paediatric population 2000–2012.
Abstract G13 Figure 2 Percentage of paediatric admissions due to
head injury (HI) 2000–2012.
Abstract G13 Figure 3 Annual number of head injury deaths per 100
000 paediatric population 2000–2012.
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